EricPLesterMD

Oncology • Saint Joseph, MI

Physician

Join to view full profile

Are you Dr. Lester?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 39 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
820 Lester Ave
Ste 119
Saint Joseph, MI 49085
Phone+1 269-385-0029

Fax+1 269-985-0040
Is this information wrong?

Summary

Dr. Eric Lester, MD is an oncologist in Saint Joseph, Michigan. He is currently licensed to practice medicine in Michigan, Minnesota, and Illinois.

Education & Training

University of ChicagoFellowship, Hematology and Medical Oncology, 1975 - 1977
University of ChicagoResidency, Internal Medicine, 1972 - 1975
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1972

Certifications & Licensure

MI State Medical License 1991 - 2020
IL State Medical License 1973 - 2014
MN State Medical License 2011 - 2012
PA State Medical License Active through 2012

Clinical Trials

Decitabine in Treating Patients With Myelofibrosis Start of enrollment: 2004 Sep 29
Active, not recruiting
Phase 2
Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction Start of enrollment: 2006 Oct 23
Active, not recruiting
Phase 1, Phase 2
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2006 Sep 15
Completed
Phase 2
Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors Start of enrollment: 2009 Mar 16
Completed
Phase 2
MK2206 in Treating Patients With Advanced Liver Cancer That Did Not Respond to Previous Therapy Start of enrollment: 2010 Dec 01
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

17 citations
Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistance.
David J. Monsma, David Cherba, Patrick J. Richardson, Sean Vance, Sanjeet Rangarajan, Dawna Dylewski, Emily Eugster, Stephanie B. Scott, Nicole L. Beuschel, Paula J. D...> ;Pediatric Blood & Cancer. 2014 Sep 1
154 citations
Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium
Sonali M. Smith, Koen van Besien, Theodore Karrison, Janet Dancey, Peter McLaughlin, Anas Younes, Scott Smith, Patrick J. Stiff, Eric P. Lester, Sanjiv Modi, L. Austin...> ;Journal of Clinical Oncology. 2010 Nov 1
56 citations
Epidermal Growth Factor Receptor Inhibitor Gefitinib Added to Chemoradiotherapy in Locally Advanced Head and Neck Cancer
Ezra E.W. Cohen, Daniel J. Haraf, Rangesh Kunnavakkam, Kerstin M. Stenson, Elizabeth A. Blair, Bruce Brockstein, Eric P. Lester, Joseph K. Salama, Allison Dekker, R. W...> ;Journal of Clinical Oncology. 2010 Jul 10
Activity of single agent temsirolimus (CCI-779) in non-mantle cell non-Hodgkin lymphoma subtypes.
Smith SM, Pro B, Cisneros A, Smith S, Stiff P, Lester E, Modi S, Dancey JE, Vokes EE, van Besien K> ;J. Clin. Oncol.. 2008-05-20
56 citations
Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer.
Nicholas W. Choong, Ann M. Mauer, Daniel J. Haraf, Eric P. Lester, Philip C. Hoffman, Mark Kozloff, Shang Lin, Janet Dancey, Livia Szeto, Tatyana A. Grushko, Olufunmil...> ;Journal of Thoracic Oncology. 2007 Aug 1
58 citations
Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762)
Stuart M. Lichtman, Donna Hollis, Antonius A. Miller, Gary L. Rosner, Chris A. Rhoades, Eric P. Lester, Frederick Millard, John C. Byrd, Stephen A. Cullinan, D. Marc R...> ;Journal of Clinical Oncology. 2006 Apr 20
18 citations
A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma
Amy C. Peterson, Helena Harlin, Theodore Karrison, Nicholas J. Vogelzang, James A. Knost, John W. Kugler, Eric P. Lester, Everett E. Vokes, Thomas F. Gajewski, Walter ...> ;Investigational New Drugs. 2006 Feb 28
Integration of gefitinib (G), into a concurrent chemoradiation (CRT) regimen followed by G adjuvant therapy in patients with locally advanced head and neck cancer (HNC...
Cohen EEW, Haraf DJ, Stenson KM, Blair E, Brockstein BE, Mauer AM, Dekker A, Williams R, Lester E, Vokes EE> ;J. Clin. Oncol.. 2005-06-01
A phase I study of erlotinib in combination with chemoradiation (CRT) for unresectable, locally advanced non-small cell lung cancer (NSCLC).
Hoffman PC, Mauer AM, Haraf DC, Lester EP, Szeto LL, Vokes EE> ;J. Clin. Oncol.. 2005-06-01
A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyelo...
Hesketh, P.J., Arena, F., Patel, D., Austin, M., D'Avirro, P., Rossi, G., Colowick, A., Schwartzberg, L., Bertoli, L.F., Cole, J.T., Demetri, G., Dessypris, E., Dobbs,...> ;Cancer. 2004 Feb 15
Irinotecan plus gemcitabine induces both radiographic and CA 19-9 tumor marker responses in patients with previously untreated advanced pancreatic cancer.
Rocha Lima, C. M., Savarese, D., Bruckner, H., Dudek, A., Eckardt, J., Hainsworth, J., Yunus, F., Lester, E., Miller, W., Saville, W., Elfring, G. L., Locker, P. K., C...> ;J Clin Oncol. 2002 Mar 1
4 citations
Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Etoposide (CHOPE) for Advanced-Stage Hodgkin's Disease: CALGB 8856
Eric P. Lester, Gina R. Petroni, Maurice Barcos, Jeffrey L. Johnson, Fred E. Millard, M. Robert Cooper, George A. Omura, Emil Frei, Bruce A. Peterson> ;Cancer Investigation. 2001 May 31
78 citations
Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473.
C. Patrick Burns, Susan Halabi, Gerald H. Clamon, Vera Hars, Brett A. Wagner, Raymond J. Hohl, Eric Lester, Jeffrey J. Kirshner, Vincent Vinciguerra, Electra D. Paskett> ;Clinical Cancer Research. 1999 Dec 1
18 citations
Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.
Ilias Athanasiadis, Samuel Taylor, Everett E. Vokes, Harold J. Pelzer, Alfred Rademaker, Bharat B. Mittal, Natalia Ganzenko, Richard R. Blough, Eric P. Lester, Merrill...> ;Cancer. 1997 Feb 1
24 citations
Adjusting the dose of intravenous ondansetron plus dexamethasone to the emetogenic potential of the chemotherapy regimen.
Paul J. Hesketh, Thomas M. Beck, M Uhlenhopp, Mark G. Kris, John D. Hainsworth, W G Harker, J R Cohen, Eric P. Lester, J F Kessler, D Griffen> ;Journal of Clinical Oncology. 1995 Aug 1
69 citations
Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of...
Thomas M. Beck, Paul J. Hesketh, Stefan Madajewicz, Rudolph M. Navari, Kelly Pendergrass, Eric P. Lester, J A Kish, W K Murphy, John D. Hainsworth, David R. Gandara> ;Journal of Clinical Oncology. 1992 Dec 1
9 citations
Concomitant cisplatin and hyperfractionated external beam irradiation for advanced malignancy of the head and neck.
James Fontanesi, Neal S. Beckford, Eric P. Lester, Kevin T. Kavanaugh, Doug Tai, Terry Eddy, Larry E. Kun> ;American Journal of Surgery. 1991 Oct 1
Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution.
Vokes, E. E., Mick, R., Lester, E. P., Panje, W. R., Weichselbaum, R. R.> ;J Clin Oncol. 1991 Aug
23 citations
Ondansetron for the prevention of emesis induced by high-dose cisplatin. A multi-center dose-response study
Ali Khojasteh, George P. Sartiano, Efstathios Tapazoglou, Eric P. Lester, David R. Gandara, Stephen A. Bernard, Andrew L. Finn> ;Cancer. 1990 Sep 15
7 citations
Two simple translocations in a primary squamous cell carcinoma of the head and neck.
Sugandhi A. Tharapel, Eric P. Lester> ;Cancer Genetics and Cytogenetics. 1990 Jul 1
5 citations
Interferon therapy of relapsed and refractory Hodgkin's disease: Cancer and Leukemia Group B Study 8652.
Mary Ellen Rybak, Kathleen McCarroll, Steven Bernard, Eric P. Lester, Maurice Barcos, Howard Ozer, Clara D. Bloomfield, Arlan J. Gottlieb> ;Journal of Biological Response Modifiers. 1990 Jan 1
77 citations
GR 38032F (GR-C507/75): A Novel Compound Effective in the Prevention of Acute Cisplatin-Induced Emesis
Paul J. Hesketh, William K. Murphy, Eric P. Lester, David R. Gandara, Ali Khojasteh, Efstathios Tapazoglou, George P. Sartiano, Douglas R. White, Karen Werner, James M...> ;Journal of Clinical Oncology. 1989 Jun 1
2 citations
Brush cytology for the early detection of esophageal carcinoma among patients with upper aerodigestive malignancies.
Kambiz Dowlatshahi, Eric P. Lester, Marluce Bibbo, Charles F. Johnson> ;The Laryngoscope. 1985 Aug 1
4 citations
Lymphocyte blastogenesis. Post-transcriptional controls of protein synthesis.
Eric P. Lester, Herbert L. Cooper> ;Biochimica Et Biophysica Acta. 1985 Apr 19
7 citations
Protein indexing in leukemias and lymphomas.
Eric P. Lester, Peter F. Lemkin, Lewis E. Lipkin> ;Annals of the New York Academy of Sciences. 1984 Jun 1
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member